PortfoliosLab logo

Takeda Pharmaceutical Company Limited (TAK)

Equity · Currency in USD
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
ISIN
US8740602052
CUSIP
874060205

TAKPrice Chart


Chart placeholderClick Calculate to get results

TAKPerformance

The chart shows the growth of $10,000 invested in Takeda Pharmaceutical Company Limited on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $8,788 for a total return of roughly -12.12%. All prices are adjusted for splits and dividends.


TAK (Takeda Pharmaceutical Company Limited)
Benchmark (S&P 500)

TAKReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
YTD8.22%-2.17%
1M8.70%0.62%
6M-13.34%6.95%
1Y-18.33%22.39%
5Y-5.05%15.44%
10Y-0.54%13.73%

TAKMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

TAKSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Takeda Pharmaceutical Company Limited Sharpe ratio is -0.69. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


TAK (Takeda Pharmaceutical Company Limited)
Benchmark (S&P 500)

TAKDividends

Takeda Pharmaceutical Company Limited granted a 5.45% dividend yield in the last twelve months, as of Jan 15, 2022. The annual payout for that period amounted to $0.80 per share.


PeriodTTM202120202019201820172016201520142013201220112010
Dividend$0.80$0.80$0.85$0.83$0.80$0.80$0.83$0.73$0.82$0.89$1.11$1.13$0.98

Dividend yield

5.45%5.90%4.67%4.20%4.98%3.03%4.45%3.37%4.71%4.79%6.38%6.89%5.64%

TAKDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


TAK (Takeda Pharmaceutical Company Limited)
Benchmark (S&P 500)

TAKWorst Drawdowns

The table below shows the maximum drawdowns of the Takeda Pharmaceutical Company Limited. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Takeda Pharmaceutical Company Limited is 54.25%, recorded on Mar 18, 2020. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-54.25%Jan 29, 2018538Mar 18, 2020
-22.13%Mar 9, 2015445Dec 8, 2016109May 17, 2017554
-21.71%Apr 26, 2013416Dec 16, 201451Mar 3, 2015467
-17.62%Sep 30, 201144Dec 1, 2011157Jul 18, 2012201
-15.93%Jan 5, 2010106Jun 7, 201086Oct 7, 2010192
-10.93%Mar 1, 201112Mar 16, 2011135Sep 27, 2011147
-8.91%Mar 28, 20133Apr 2, 201316Apr 24, 201319
-5.94%Nov 9, 201013Nov 26, 201025Jan 3, 201138
-5.75%Sep 25, 201266Dec 31, 20128Jan 11, 201374
-5.57%Nov 2, 201728Dec 12, 20179Dec 26, 201737

TAKVolatility Chart

Current Takeda Pharmaceutical Company Limited volatility is 21.44%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


TAK (Takeda Pharmaceutical Company Limited)
Benchmark (S&P 500)

Portfolios with Takeda Pharmaceutical Company Limited


Loading data...

More Tools for Takeda Pharmaceutical Company Limited